NasdaqGM - Nasdaq Real Time Price USD

Arcturus Therapeutics Holdings Inc. (ARCT)

Compare
21.37 +0.40 (+1.90%)
As of 10:14 AM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
147,028.00
157,748.00
205,755.00
12,359.00
9,539.00
Operating Expense
236,152.00
235,953.00
193,578.00
215,211.00
81,063.00
Operating Income
-89,124.00
-78,205.00
12,177.00
-202,852.00
-71,524.00
Net Non Operating Interest Income Expense
19,027.00
16,592.00
-420.00
-1,921.00
-361.00
Other Income Expense
-491.00
33,724.00
-1,113.00
1,099.00
-263.00
Pretax Income
-70,589.00
-27,890.00
10,644.00
-203,674.00
-72,148.00
Tax Provision
1,373.00
1,835.00
1,295.00
--
--
Net Income Common Stockholders
-71,962.00
-29,725.00
9,349.00
-203,674.00
-72,148.00
Diluted NI Available to Com Stockholders
-71,962.00
-29,725.00
9,349.00
-203,674.00
-72,148.00
Basic EPS
-2.69
-1.00
0.35
-7.74
-3.55
Diluted EPS
-2.69
-1.00
0.35
-7.74
-3.55
Basic Average Shares
26,811.00
26,628.00
26,445.00
26,317.00
20,305.00
Diluted Average Shares
26,811.00
26,628.00
27,093.00
26,317.00
20,305.00
Total Operating Income as Reported
-89,124.00
-78,205.00
12,177.00
-202,852.00
-71,524.00
Total Expenses
236,152.00
235,953.00
193,578.00
215,211.00
81,063.00
Net Income from Continuing & Discontinued Operation
-71,962.00
-29,725.00
9,349.00
-203,674.00
-72,148.00
Normalized Income
-71,574.11
-56,366.96
9,874.04
-204,258.00
-72,148.00
Interest Income
19,051.00
17,359.00
2,581.00
753.00
470.00
Interest Expense
24.00
767.00
3,001.00
2,674.00
831.00
Net Interest Income
19,027.00
16,592.00
-420.00
-1,921.00
-361.00
EBIT
-70,565.00
-27,123.00
13,645.00
-202,852.00
-71,317.00
EBITDA
-67,110.00
-24,166.00
15,172.00
-201,659.00
-70,435.00
Reconciled Depreciation
3,455.00
2,957.00
1,527.00
1,193.00
882.00
Net Income from Continuing Operation Net Minority Interest
-71,962.00
-29,725.00
9,349.00
-203,674.00
-72,148.00
Total Unusual Items Excluding Goodwill
-491.00
33,724.00
-598.00
584.00
--
Total Unusual Items
-491.00
33,724.00
-598.00
584.00
--
Normalized EBITDA
-66,619.00
-57,890.00
15,770.00
-202,243.00
-70,435.00
Tax Rate for Calcs
0.00
0.00
0.00
--
--
Tax Effect of Unusual Items
-103.11
7,082.04
-72.96
--
--
12/31/2020 - 5/22/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers